Atlas Trials

Single Cohort, 2-Period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine 500 mg

Clinical trial NCT01546558 · COMPLETED

Trial details

NCT number
NCT01546558
Sponsor
Gilead Sciences
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2012-02-01
Primary completion
2012-03-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.